GEN Exclusives

More »

GEN News Highlights

More »
Dec 7, 2009

BioLife to Produce Custom Biopreservation Media for Centocor

  • BioLife Solutions signed a license and custom cGMP manufaturing agreement with Centocor R&D. The company will produce a variant of its serum-free and protein-free CryoStor biopreservation media product, which is formulated with a reduced concentration of 2% DMSO.

    BioLife specializes in the development of patented hypothermic storage/transport and cryopreservation media products for cells, tissues, and organs. The company claims its GMP products are serum/protein-free and preformulated to reduce delayed-onset cell damage and death.

    In November BioLife was granted a Japanese patent covering claims related to protecting cells from injury and death caused by cold temperatures used in biopreservation. BioLife was previously granted equivalent U.S. and European patent protection for the IP. In September Sigma Aldrich negotiated a nonexclusive distribution agreement for BioLife’s HypoThermosol and CryoStor products.


Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »